Related topics

Zynerba: 3Q Earnings Snapshot

November 6, 2019 GMT

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Wednesday reported a loss of $1.9 million in its third quarter.

On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 8 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

Zynerba shares have more than doubled since the beginning of the year. The stock has risen 21% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE